Slx Pharmaceuticals LLC San Francisco, CA - 94124

Slx Pharmaceuticals LLC is categorized under Wholesale Pharmaceutical Products in San Francisco, CA and active since 2012.

Slx Pharmaceuticals LLC was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.

If you are seeking more information, feel free to contact Jonathan Wray at the company’s single location by writing to 6601 3rd St, San Francisco, California CA 94124 or by phoning (415) 715-0247. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Slx Pharmaceuticals LLC
Contact Person: Jonathan Wray
Address: 6601 3rd St, San Francisco, California 94124
Phone Number: (415) 715-0247
Annual Revenue (USD): $100.000 to $499.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Wholesale Pharmaceutical Products
SIC Code: 5122
NAICS Code: 424210
Share This Business:

Slx Pharmaceuticals LLC was started in 2012 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Jonathan Wray for inquiries that concern Slx Pharmaceuticals LLC by calling the company number (415) 715-0247, as your correspondence is most welcome. Additionally, the physical location of the single location of Slx Pharmaceuticals LLC can be found at the coordinates 37.718589,-122.397386 as well as the street address 6601 3rd St in San Francisco, California 94124.

For its online presence, you may visit Slx Pharmaceuticals LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.